BASSE-TERRE, France A French woman from the Caribbean island of Guadeloupe has been identified as the only known carrier of a ...

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type-1 diabetes, hepatitis, ...

Explore the rapidly growing Global Vectorized Antibodies Market, projected to soar from USD 9.49 billion in 2025 to USD 15.94 billion by 2034 at a CAGR of 7.7%. Transforming biotherapeutics, this ...

TECH teams up with USP to boost mAb and gene therapy testing, aiming to simplify analytics and enhance product quality.

Levinson, Ph.D., today announced an exclusive licensing agreement for IL-11 directed therapeutics, including 9MW3811, a Phase I monoclonal antibody (mAb). Preclinically, Mabwell has explored the ...